On May 8, the Government issued Ministerial Resolution No. 270-2020-MINSA, where the Technical Document: Prevention, Diagnosis and Treatment of people affected by COVID-19 in Peru is modified, and includes Azithromycin, Hydroxychloroquine and Ivermectin as medicines for the treatment of patients with coronavirus.
Since then it has been an odyssey to get such drugs, pharmaceutical companies began to speculate on prices. The cost of medicine doubled and began to run low, making it difficult to buy.
Recently, the World Health Organization observed the use of Hydroxychloroquine, since it generated contraindications in patients. But Ivermectin has been shown to be effective in some cases.
According to the Regional Director of Health of Piura, Víctor Távara, 100% of mild positive COVID-19 patients have improved with Ivermectin.
100% sounds like they weren't really tracking.
"At first we were applying Hydroxychloroquine, however, given the adherence of the treatment and seeing that it has fewer side effects, we preferred to use Ivermectin. In mild patients it is 100% effective and in moderate 95%. In serious cases it does not give results ”, he expressed.
95% sounds like they might be tracking?!
#What does the Minsa say about the treatment?
Minsa = Ministry of Health, I think.
Távara pointed out that the treatment medication is based on the symptoms of the patients and that Minsa established the freedom to supply, it is not an obligation.
So far, the Ministry of Health has not modified the list of medications and its recommendations for mild, moderate and severe patients.
The prescription and medication for treatments for coronavirus patients are issued only by healthcare professionals.
For minor cases, the Minsa offers the following treatment guidelines to doctors:
[Go to the article to see the charts]
Physicians may indicate treatment based on an individual case evaluation, with prior informed consent, and should monitor adverse events of the prescribed drugs.
Mild cases can be managed on an outpatient basis in establishments of the first level of care, with a doctor.
Physicians will be able to indicate treatment based on an individual case evaluation, with prior informed consent, and should closely monitor adverse events of the prescribed drugs.
Treatment options must be explained in detail to the patient, who must be informed and give their authorization, the treatment must be strictly supervised.
All medications must be prescribed by a doctor, self-medication could have fatal consequences.
FALSE. Well, HCQ will kill people with the wrong heart condition. Ivermectin is ridiculously safe.
#Data:
* Diresa has been delivering 8 thousand kits of this medicine that prevents patients from aggravating and being hospitalized.
* Despite the fact that Hydroxychloroquine has contradictions (Hypersensitivity to the active ingredient, myasthenia gravis, retinopathy, ocular maculopathy, disorders of the hematopoietic system, pregnancy and lactation), Minsa still recommends its use.
[-] TrumpLyftAlles | 1 points | Jun 08 2020 00:02:02
Ivermectin getting more expensive in Peru. :(
On May 8, the Government issued Ministerial Resolution No. 270-2020-MINSA, where the Technical Document: Prevention, Diagnosis and Treatment of people affected by COVID-19 in Peru is modified, and includes Azithromycin, Hydroxychloroquine and Ivermectin as medicines for the treatment of patients with coronavirus.
Since then it has been an odyssey to get such drugs, pharmaceutical companies began to speculate on prices. The cost of medicine doubled and began to run low, making it difficult to buy.
Recently, the World Health Organization observed the use of Hydroxychloroquine, since it generated contraindications in patients. But Ivermectin has been shown to be effective in some cases.
According to the Regional Director of Health of Piura, Víctor Távara, 100% of mild positive COVID-19 patients have improved with Ivermectin.
100% sounds like they weren't really tracking.
"At first we were applying Hydroxychloroquine, however, given the adherence of the treatment and seeing that it has fewer side effects, we preferred to use Ivermectin. In mild patients it is 100% effective and in moderate 95%. In serious cases it does not give results ”, he expressed.
95% sounds like they might be tracking?!
#What does the Minsa say about the treatment?
Minsa = Ministry of Health, I think.
Távara pointed out that the treatment medication is based on the symptoms of the patients and that Minsa established the freedom to supply, it is not an obligation.
So far, the Ministry of Health has not modified the list of medications and its recommendations for mild, moderate and severe patients.
The prescription and medication for treatments for coronavirus patients are issued only by healthcare professionals.
For minor cases, the Minsa offers the following treatment guidelines to doctors:
[Go to the article to see the charts]
Physicians may indicate treatment based on an individual case evaluation, with prior informed consent, and should monitor adverse events of the prescribed drugs.
Mild cases can be managed on an outpatient basis in establishments of the first level of care, with a doctor.
Physicians will be able to indicate treatment based on an individual case evaluation, with prior informed consent, and should closely monitor adverse events of the prescribed drugs.
Treatment options must be explained in detail to the patient, who must be informed and give their authorization, the treatment must be strictly supervised.
All medications must be prescribed by a doctor, self-medication could have fatal consequences.
FALSE. Well, HCQ will kill people with the wrong heart condition. Ivermectin is ridiculously safe.
#Data:
* Diresa has been delivering 8 thousand kits of this medicine that prevents patients from aggravating and being hospitalized. * Despite the fact that Hydroxychloroquine has contradictions (Hypersensitivity to the active ingredient, myasthenia gravis, retinopathy, ocular maculopathy, disorders of the hematopoietic system, pregnancy and lactation), Minsa still recommends its use.
permalink